EN
enGene Holdings Inc. (ENGN)
NASDAQ·Healthcare·Biotechnology
$7.03
-2.43%
Mkt Cap $409.05M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | — | — | — | -$0.55 | -$0.44 | +20.00% | — | — |
| Q4 2025 Dec 22, 2025 | — | — | — | -$0.57 | -$0.73 | -28.77% | — | — |
| Q3 2025 Sep 11, 2025 | — | — | — | -$0.50 | -$0.57 | -14.46% | — | — |
| Q2 2025 Jun 12, 2025 | — | — | — | -$0.50 | -$0.51 | -2.56% | — | — |
| Q1 2025 Mar 10, 2025 | — | — | — | -$0.37 | -$0.48 | -30.51% | — | — |
| Q4 2024 Dec 19, 2024 | — | $480.00K | — | -$0.40 | -$0.34 | +14.08% | — | — |
| Q3 2024 Sep 10, 2024 | — | — | — | -$0.37 | -$0.32 | +13.51% | — | — |
| Q2 2024 Jun 14, 2024 | — | — | — | -$0.26 | -$0.38 | -46.15% | — | — |
| Q1 2024 Mar 11, 2024 | — | — | — | -$0.41 | -$0.46 | -11.26% | — | — |
| Q1 2024 Jan 29, 2024 | — | — | — | — | -$2.64 | — | — | — |
| Q3 2023 Jul 31, 2023 | — | — | — | — | -$0.30 | — | — | — |
| Q2 2023 Apr 30, 2023 | — | — | — | — | -$0.33 | — | — | — |
| Q1 2023 Jan 31, 2023 | — | — | — | — | -$0.47 | — | — | — |
| Q4 2022 Oct 31, 2022 | — | — | — | — | -$0.53 | — | — | — |
| Q3 2022 Jul 31, 2022 | — | — | — | — | -$0.43 | — | — | — |
| Q2 2022 Apr 30, 2022 | — | — | — | — | -$0.34 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.01 | — | — | — |